To fill the growing need for clinical trials, MindLeaf Technologies developed a data management platform to help organizations recruit subjects while adhering to the FDA mandate around DEI requirement...
LOWELL, Mass.: To fill the growing need for clinical trials, MindLeaf Technologies developed a data management platform to help organizations recruit subjects while adhering to the FDA mandate around DEI requirements while providing patient engagement services to ensure patients will stay in the trial. The platform allows organizations at each clinical trial phase: pre-trial, recruitment, in-trial, and post-trial to collect data to provide a holistic view of the trial/site/patients.
After 2 years of development and beta testing in the market, MindLeaf is excited to announce that it will spin off the life sciences division as CliniLink Health, which will operate independently from MindLeaf Technologies. CliniLink Health will emerge as an entirely separate entity dedicated to providing data collection solutions and services that focus solely on clinical trials.
Having been in operation for over 20 years, Paresh Shah, the CEO of MindLeaf Technologies, identified a gap in the clinical trials’ patient engagement, which led to a low percentage of clinical trials completed. He quickly moved to fill the void by establishing a patient engagement platform.
The birth of CliniLink Health comes after comprehensive testing and validation by speaking to expert industry leaders and specialists. CliniLink Health will focus on revolutionizing clinical trials through services that address the needs of CROs and healthcare organizations.
Using CliniLink Health in clinical trials will help achieve better results by providing services that address every clinical trial stage. From the early planning stages to execution and data analysis, CliniLink services will facilitate the better organization of clinical trials and adequate preparation for patient recruitment, DEI, and SDOH while running clinical trials.
The company intends to achieve this by:
This new platform will offer services that include DEI analysis during patient recruitment, patient onboarding and engagement, risk management for patients dropping out, and SDOH analysis. By doing this, CliniLink Health hopes to improve the performance and outcomes of clinical trials and patient recruitment.
After the spinoff, MindLeaf Technologies will keep its primary function and mission of offering its services to federal and state government healthcare organizations. At the same time, CliniLink Health grows independently with its dedication to clinical trials.
About MindLeaf Technologies
Founded in 1993, MindLeaf Technologies, led by CEO, Paresh Shah, supports healthcare companies with medical and compliance support services. With a team of professionals, the company serves hospitals, clinics, healthcare facilities, clearinghouses, and payer organizations nationwide.
MindLeaf Technologies focus includes medical health management, medical scribes, medical appointing, medical compliance, clinical trials, medical coding and auditing, and patient management. Visit https://www.mindleaf.com for more information!
Contacts For media inquiries:
Wendy Austin
wendy@wsihds.com
203-433-5451
Fonte: Business Wire
Alaa Abdul Nabi, Vice President, Sales International at RSA presents the innovations the vendor brings to Cybertech as part of a passwordless vision for…
G11 Media's SecurityOpenLab magazine rewards excellence in cybersecurity: the best vendors based on user votes
Always keeping an European perspective, Austria has developed a thriving AI ecosystem that now can attract talents and companies from other countries
Successfully completing a Proof of Concept implementation in Athens, the two Italian companies prove that QKD can be easily implemented also in pre-existing…
Red Hat, the world's leading provider of open source solutions, today continues to deliver customer choice in enterprise AI with the introduction of Red…
The "U.S. Data Center Construction Market - Industry Outlook & Forecast 2025-2030" report has been added to ResearchAndMarkets.com's offering. The…
J.D. Power today announced that Joshua Peirez will assume the role of President and CEO of J.D. Power, guiding the company in its next phase of growth…
#ATS--IMVARIA Inc., a health tech company pioneering AI-driven digital biomarker solutions, today reported results from multi-site clinical experiences…